Relmada Therapeutics (RLMD) Price to Book Value: 1.683

Relmada Therapeutics, Inc. (RLMD)

3.26 -0.02 (-0.61%) USD | NASDAQ | Oct 07, 16:00

3.26 0.00 (0.00%) After-Hours: 20:00

Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2014. Start Trial.

Date	Value
October 06, 2026	1.694
October 05, 2026	1.797
October 02, 2026	1.859
October 01, 2026	1.890
September 30, 2026	1.947
September 29, 2026	1.926
September 28, 2026	1.957
September 25, 2026	1.978
September 24, 2026	1.968
September 23, 2026	1.952
September 22, 2026	2.190
September 21, 2026	2.148
September 18, 2026	2.128
September 17, 2026	2.169
September 16, 2026	2.179
September 15, 2026	2.293
September 14, 2026	2.293
September 11, 2026	2.334
September 10, 2026	2.102
September 09, 2026	2.112
September 08, 2026	2.195
September 04, 2026	2.288
September 03, 2026	2.257
September 02, 2026	2.344
September 01, 2026	2.303

Date	Value
August 31, 2026	2.252
August 28, 2026	2.236
August 27, 2026	2.334
August 26, 2026	2.350
August 25, 2026	2.370
August 24, 2026	2.365
August 21, 2026	2.391
August 20, 2026	2.396
August 19, 2026	2.494
August 18, 2026	2.505
August 17, 2026	2.463
August 14, 2026	2.479
August 13, 2026	2.453
August 12, 2026	2.438
August 11, 2026	2.308
August 10, 2026	2.344
August 07, 2026	2.551
August 06, 2026	2.773
August 05, 2026	2.809
August 04, 2026	2.825
August 03, 2026	2.737
July 31, 2026	2.742
July 30, 2026	2.763
July 29, 2026	2.654
July 28, 2026	2.701

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks